
Board Meeting5 Nov 2026, 11:08 am
Expleo Solutions Board Meeting on Nov 14 to Approve Q2 FY27 Results
AI Summary
Expleo Solutions Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda items include the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. This meeting is a routine procedural step for financial reporting.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- Agenda includes approval of financial results.
- Covers both standalone and consolidated statements.
- Reporting period is for the quarter and half-year ended September 30, 2026.
Price Impact
More from EXPLEOSOL